Fusion Historical Income Statement
| FSPM Stock | USD 0.0001 0.00 0.00% |
Historical analysis of Fusion Pharm income statement accounts such as Selling General Administrative of 164 K or Total Revenue of 717.7 K can show how well Fusion Pharm performed in making a profits. Evaluating Fusion Pharm income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fusion Pharm's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Fusion Pharm latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fusion Pharm is a good buy for the upcoming year.
Fusion |
About Fusion Income Statement Analysis
Fusion Pharm Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fusion Pharm shareholders. The income statement also shows Fusion investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Fusion Pharm Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Fusion Pharm generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Fusion Pharm minus its cost of goods sold. It is profit before Fusion Pharm operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Cost Of Revenue
Cost of Revenue is found on Fusion Pharm income statement and represents the costs associated with goods and services Fusion Pharm provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Fusion Pharm's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fusion Pharm current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.At this time, Fusion Pharm's Selling General Administrative is very stable compared to the past year. As of the 25th of March 2025, Total Revenue is likely to grow to about 717.7 K, though Net Loss is likely to grow to (36 K).
| 2012 | 2013 | 2024 | 2025 (projected) | Gross Profit | 85.7K | 120.5K | 138.6K | 145.5K | Total Revenue | 308.4K | 594.4K | 683.6K | 717.7K |
Fusion Pharm income statement Correlations
Click cells to compare fundamentals
Fusion Pharm Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.